uric acid has been researched along with Thromboembolism in 13 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Thromboembolism: Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Uric acid is a natural antioxidant that protects the brain in a model of transient focal ischemia in rats." | 5.34 | Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke. ( Amaro, S; Chamorro, A; Planas, AM; Romanos, E, 2007) |
| " Although hyperuricemia is a risk factor for cardiovascular diseases, the relationship between serum uric acid (UA) levels and thromboembolic risk has not been fully elucidated in patients with AF." | 5.19 | Hyperuricemia and transesophageal echocardiographic thromboembolic risk in patients with atrial fibrillation at clinically low-intermediate risk. ( Fukuda, N; Hirai, T; Inoue, H; Nakagawa, K; Nozawa, T; Numa, S; Ohara, K, 2014) |
| "Uric acid is a natural antioxidant that protects the brain in a model of transient focal ischemia in rats." | 1.34 | Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke. ( Amaro, S; Chamorro, A; Planas, AM; Romanos, E, 2007) |
| "Twenty-six transfusions (5." | 1.33 | Risk factors for post-partum complications occurring after preeclampsia and HELLP syndrome. A study in 453 consecutive pregnancies. ( Codaccioni, X; Coudoux, E; Deruelle, P; Ego, A; Houfflin-Debarge, V; Subtil, D, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (53.85) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Cicero, AFG | 1 |
| Fogacci, F | 1 |
| Borghi, C | 1 |
| Numa, S | 1 |
| Hirai, T | 1 |
| Nakagawa, K | 1 |
| Ohara, K | 1 |
| Fukuda, N | 1 |
| Nozawa, T | 1 |
| Inoue, H | 1 |
| Fricker, J | 1 |
| Deruelle, P | 1 |
| Coudoux, E | 1 |
| Ego, A | 1 |
| Houfflin-Debarge, V | 1 |
| Codaccioni, X | 1 |
| Subtil, D | 1 |
| Romanos, E | 1 |
| Planas, AM | 1 |
| Amaro, S | 1 |
| Chamorro, A | 1 |
| Steele, P | 1 |
| Rainwater, J | 1 |
| Abbott, RD | 1 |
| Curb, JD | 1 |
| Rodriguez, BL | 1 |
| Sharp, DS | 1 |
| Burchfiel, CM | 1 |
| Yano, K | 1 |
| Mertz, DP | 1 |
| Zöller, H | 1 |
| Gross, W | 1 |
| Rieke, K | 1 |
| Khalifa, P | 1 |
| Sereni, D | 1 |
| Boissonnas, A | 1 |
| Cremer, GA | 1 |
| Laroche, C | 1 |
| Kramer, HJ | 1 |
| Krück, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized, Double Blind Study Assessing the Clinical Efficacy of Combined Treatment With Uric Acid and rtPA Administered Intravenously in Acute Ischemic Stroke Patients Within the First 4.5 Hours of Symptoms Onset[NCT00860366] | Phase 2/Phase 3 | 421 participants (Actual) | Interventional | 2011-06-30 | Completed | ||
| [NCT00005123] | 0 participants | Observational | 1965-07-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for uric acid and Thromboembolism
| Article | Year |
|---|---|
[Significance of physical activity in the prevention of degenerative heart and vascular diseases?].
Topics: Adult; Age Factors; Arteriosclerosis; Body Weight; Cerebral Hemorrhage; Cerebrovascular Disorders; C | 1976 |
[Pharmacological bases of diuretic therapy. 2].
Topics: Acidosis; Alkalosis; Digitalis Glycosides; Diuretics; Drug Synergism; Edema; Gastrointestinal Hemorr | 1974 |
1 trial available for uric acid and Thromboembolism
| Article | Year |
|---|---|
Hyperuricemia and transesophageal echocardiographic thromboembolic risk in patients with atrial fibrillation at clinically low-intermediate risk.
Topics: Adult; Aged; Atrial Fibrillation; Echocardiography, Transesophageal; Female; Humans; Hyperuricemia; | 2014 |
10 other studies available for uric acid and Thromboembolism
| Article | Year |
|---|---|
Uric acid and thrombotic risk: an emerging link.
Topics: Cardiomyopathy, Hypertrophic; Humans; Hyperuricemia; Risk Factors; Thromboembolism; Uric Acid | 2020 |
50th ASH Annual Meeting.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Humans; Lenalidomide; Leukemia, Lymp | 2009 |
Risk factors for post-partum complications occurring after preeclampsia and HELLP syndrome. A study in 453 consecutive pregnancies.
Topics: Abscess; Adult; Ascites; Cesarean Section; Creatinine; Disseminated Intravascular Coagulation; Femal | 2006 |
Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke.
Topics: Animals; Brain Damage, Chronic; Brain Edema; Humans; Infarction, Middle Cerebral Artery; Male; Neuro | 2007 |
Favorable effect of sulfinpyrazone on thromboembolism in patients with rheumatic heart disease.
Topics: Atrial Fibrillation; Blood Coagulation; Blood Platelets; Cell Survival; Heart Valve Prosthesis; Huma | 1980 |
Effect of dietary calcium and milk consumption on risk of thromboembolic stroke in older middle-aged men. The Honolulu Heart Program.
Topics: Age Factors; Aged; Alcohol Drinking; Animals; Blood Glucose; Body Mass Index; Calcium, Dietary; Chol | 1996 |
[New specialties, registered in Austria. Anturane 200 mg dragees, regulator of platelet function].
Topics: Aspirin; Austria; Drug Interactions; Drug Tolerance; Pharmacopoeias as Topic; Platelet Aggregation; | 1979 |
Clotting properties in diverse valve prostheses.
Topics: Bioprosthesis; Blood Coagulation Tests; Female; Heart Valve Diseases; Heart Valve Prosthesis; Hemoly | 1986 |
[Attacks of gout and thromboembolic disease: role of heparin therapy].
Topics: Acute Disease; Aged; Arthritis; Female; Gout; Heparin; Humans; Male; Middle Aged; Thromboembolism; U | 1985 |
Hypertension, hyperuricemia and iatrogenic disease.
Topics: Aged; Allopurinol; Aortic Diseases; Arteriosclerosis; Brain; Catheterization; Chlorothiazide; Diagno | 1970 |